Crinetics Approach

News Releases

News Releases

April 15, 2020
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO , April 15, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today the
April 14, 2020
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO , April 14, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that it